Company research
Caribou Biosciences, Inc.
CIK 1619856Updated Sep 27, 2026
SecurityCRBU · NASDAQ · equity
CRBU price & chart
Loading TradingView…
NASDAQ:CRBU on TradingView ↗In the news
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference ↗
CRBU Deadline: CRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud Lawsuit News provided by THE ROSEN LAW FIRM, P. A. Feb 24, 2025, 17:05 ET Share this article Share to X Share this article Share to X NEW YORK , Feb. 24, 2025 /PRNewswire/ -- Rosen Law Firm, a global in ↗
Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBU News provided by The Gross Law Firm Feb 24, 2025, 05:45 ET Share this article Share to X Share this article Share to X NEW YORK , Feb. 24, 2025 /PRNewswire/ -- The Gross ↗
Recent filings
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Submission of Matters to a Vote of Security Holders
Items 5.07, 9.01
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
DEFA14A filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 175,367,000Source | 313,313,000Source | 432,209,000Source | 373,765,000Source |
| Property, Plant and Equipment, NetUSD | 6,760,000Source | 19,281,000Source | 18,270,000Source | 10,678,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 12,360,000Source | 16,293,000Source | 51,162,000Source | 58,338,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 69,000Source | 265,000Source | 148,000Source | 202,000Source |
| Assets, CurrentUSD | 145,232,000Source | 219,377,000Source | 338,841,000Source | 260,248,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 2,913,000Source | 6,589,000Source | 6,155,000Source | 7,921,000Source |
| Operating Lease, Right-of-Use AssetUSD | 17,670,000Source | 20,009,000Source | 22,182,000Source | 24,230,000Source |
| Other Assets, NoncurrentUSD | 2,200,000Source | 5,521,000Source | 1,586,000Source | 1,538,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 53,192,000Source | 60,362,000Source | 63,808,000Source | 72,894,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | — | — | — | 0Source |
| Common Stock, Value, IssuedUSD | 9,000Source | 9,000Source | 8,000Source | 6,000Source |
| Additional Paid in CapitalUSD | 718,578,000Source | 701,077,000Source | 667,648,000Source | 499,598,000Source |
| Retained Earnings (Accumulated Deficit)USD | -596,515,000Source | -448,390,000Source | -299,285,000Source | -197,215,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 103,000Source | 255,000Source | 30,000Source | -1,518,000Source |
| Stockholders' Equity Attributable to ParentUSD | 122,175,000Source | 252,951,000Source | 368,401,000Source | 300,871,000Source |
| Liabilities and EquityUSD | 175,367,000Source | 313,313,000Source | 432,209,000Source | 373,765,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 25,414,000Source | 30,651,000Source | 28,302,000Source | 28,128,000Source |
| Operating Lease, Liability, CurrentUSD | 1,201,000Source | 1,426,000Source | 1,200,000Source | 966,000Source |
| Accounts Payable, CurrentUSD | 5,783,000Source | 2,476,000Source | 3,120,000Source | 1,146,000Source |
| Operating Lease, Liability, NoncurrentUSD | 26,026,000Source | 25,061,000Source | 25,908,000Source | 26,780,000Source |
| Deferred Income Tax Liabilities, NetUSD | 0Source | 548,000Source | 557,000Source | 381,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 16,535,000Source | 23,620,000Source | 21,135,000Source | 16,079,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 142,800,000Source | 249,400,000Source | 372,400,000Source | 317,000,000Source |
| Deferred Tax Liabilities, NetUSD | — | 548,000Source | 557,000Source | 381,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -148,125,000Source | -149,105,000Source | -102,070,000Source | -99,421,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 3,645,000Source | 3,927,000Source | 3,525,000Source | 1,622,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 12,680,000Source | 16,706,000Source | 13,750,000Source | 11,716,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -196,000Source | 117,000Source | -54,000Source | -951,000Source |
| Increase (Decrease) in Accounts PayableUSD | 3,254,000Source | -354,000Source | 1,819,000Source | -2,721,000Source |
| Deferred Income Tax Expense (Benefit)USD | -551,000Source | -10,000Source | 178,000Source | -95,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -110,992,000Source | -138,200,000Source | -93,291,000Source | -90,966,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 102,238,000Source | 86,607,000Source | -68,183,000Source | -93,249,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 1,359,000Source | 4,880,000Source | 11,613,000Source | 6,454,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 4,821,000Source | 16,724,000Source | 154,298,000Source | 2,133,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -3,933,000Source | -34,869,000Source | -7,176,000Source | -182,082,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 12,406,000Source | 16,339,000Source | 51,208,000Source | 58,384,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Income Taxes Paid, NetUSD | — | 0Source | 170,000Source | 0Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 12,680,000Source | 16,706,000Source | 13,750,000Source | 11,716,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 142,800,000Source | 249,400,000Source | 372,400,000Source | 317,000,000Source |
| Equity Securities, FV-NI, Gain (Loss)USD | -99,000Source | -111,000Source | -6,000Source | -133,000Source |
| Gain (Loss) on Disposition of AssetsUSD | 25,000Source | 9,000Source | 34,000Source | 0Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | 0Source |
| General and Administrative ExpenseUSD | 37,914,000Source | 46,457,000Source | 38,461,000Source | 38,020,000Source |
| Income Tax Expense (Benefit)USD | -550,000Source | -9,000Source | 193,000Source | 70,000Source |
| Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment LossUSD | — | — | — | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -148,125,000Source | -149,105,000Source | -102,070,000Source | -99,421,000Source |
| Nonoperating Income (Expense)USD | -331,000Source | 17,502,000Source | 14,182,000Source | 7,048,000Source |
| Operating ExpensesUSD | 159,503,000Source | 176,610,000Source | 150,536,000Source | 120,250,000Source |
| Operating Lease, ExpenseUSD | — | — | 1,800,000Source | 1,800,000Source |
| Proceeds from Issuance of Common StockUSD | 4,070,000Source | 15,192,000Source | 1,007,000Source | — |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | — | — | — | 252,868,000Source |
| Restructuring Costs and Asset Impairment ChargesUSD | 14,426,000Source | — | — | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 11,159,000Source | 9,994,000Source | 34,477,000Source | 13,851,000Source |
| Operating Income (Loss)USD | -148,344,000Source | -166,616,000Source | -116,059,000Source | -106,399,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -148,675,000Source | -149,114,000Source | -101,877,000Source | -99,351,000Source |
| Income Tax Expense (Benefit)USD | -550,000Source | -9,000Source | 193,000Source | 70,000Source |
| Net Income (Loss) Attributable to ParentUSD | -148,125,000Source | -149,105,000Source | -102,070,000Source | -99,421,000Source |
| Earnings Per Share, BasicUSD per share | -1.59Source | -1.65Source | -1.38Source | -1.64Source |
| Earnings Per Share, DilutedUSD per share | -1.59Source | -1.65Source | -1.38Source | -1.64Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 93,389,283Source | 90,317,925Source | 73,807,597Source | 60,801,133Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 93,389,283Source | 90,317,925Source | 73,807,597Source | 60,801,133Source |
| Additional Financial Items | ||||
| Current Income Tax Expense (Benefit)USD | 1,000Source | 1,000Source | 15,000Source | 165,000Source |
| General and Administrative ExpenseUSD | 37,914,000Source | 46,457,000Source | 38,461,000Source | 38,020,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -148,700,000Source | -149,100,000Source | -101,900,000Source | -99,400,000Source |
| Nonoperating Income (Expense)USD | -331,000Source | 17,502,000Source | 14,182,000Source | 7,048,000Source |
| Operating ExpensesUSD | 159,503,000Source | 176,610,000Source | 150,536,000Source | 120,250,000Source |
| Operating Lease, ExpenseUSD | — | — | 1,800,000Source | 1,800,000Source |
| Other IncomeUSD | 8,000,000Source | 15,300,000Source | 15,300,000Source | 4,600,000Source |
| Research and Development ExpenseUSD | 109,439,000Source | 130,153,000Source | 112,075,000Source | 82,230,000Source |